CLGN
CollPlant Biotechnologies Ltd
$0.3390
+1.50%
$4.9M
No data for this timeframe.
Vol
Market Cap$4.9M
Cap SizeNano Cap
SEC Reports3
Exchange Nasdaq·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. L3·CIK 0001631487·Prev Close $0.3340
Recent Activity
May 29, 2026
SEC
CollPlant reported Q1 2026 revenue of $73K, down 96% YoY from $2.1M due to a non-recurring $2.0M milestone payment in Q1
6-K — Impact 7/10
May 26, 2026
earnings_calendar
CLGN Q1 2026 Earnings Scheduled — 2026-05-26
Apr 22, 2026
SEC
The SEC has declared effective CollPlant Biotechnologies Ltd's F-1 registration statement, enabling the resale of up to
EFFECT — Impact 6/10
Apr 13, 2026
SEC
CollPlant Biotechnologies announced the termination of its development agreement with AbbVie, which had been developing
6-K — Impact 7/10
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Feb 6, 2026 | D. Boral Capital | DOWNGRADE | Buy → Hold |
Latest Reports
BEARISH
6-K
7/10
CollPlant reported Q1 2026 revenue of $73K, down 96% YoY from $2.1M due to a non-recurring $2.0M milestone payment in Q1
May 29, 2026
BEARISH
EFFECT
6/10
The SEC has declared effective CollPlant Biotechnologies Ltd's F-1 registration statement, enabling the resale of up to
Apr 22, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 0 neutral. Avg impact: 6.7/10.
BEARISH
6-K
7/10
CollPlant reported Q1 2026 revenue of $73K, down 96% YoY from $2.1M due to a non-recurring $2.0M mil
May 29, 2026
BEARISH
EFFECT
6/10
The SEC has declared effective CollPlant Biotechnologies Ltd's F-1 registration statement, enabling
Apr 22, 2026
BEARISH
6-K
7/10
CollPlant Biotechnologies announced the termination of its development agreement with AbbVie, which
Apr 13, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Feb 2026): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Feb 6, 2026 | D. Boral Capital | DOWNGRADE | Buy | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Mar 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 26, 2026
earnings_calendar
CLGN Q1 2026 Earnings Scheduled — 2026-05-26
May 21, 2026
earnings_calendar
CLGN Q1 2026 Earnings Scheduled — 2026-05-21
Mar 26, 2026
earnings_calendar
CLGN Q4 2025 Earnings Before Market Open — 2026-03-26